Regulation of Cell Death and Mitochondrial Physiology by Anti-Apoptotic MCL-1

抗凋亡 MCL-1 对细胞死亡和线粒体生理学的调节

• 批准号: 7863093
• 负责人: JOSEPH T. OPFERMAN
• 金额: $ 42万
• 依托单位: ST. JUDE CHILDREN'S RESEARCH HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2015-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7863093
• 关键词: Ablation; Address; Affect; Apoptosis; Apoptotic; Autoimmunity; Binding; Biochemical; Biology; Blood Cells; Bone Marrow; Cancerous; Cell Death; Cell Survival; Cells; Cessation of life; Defect; Development; Equilibrium; Exhibits; Family member; Generations; Genetic; Goals; Hematopoiesis; Hematopoietic; Immunodeficiency and Cancer; Individual; Inner mitochondrial membrane; Laboratories; Lead; Light; Location; Lymphocyte; Macromolecular Complexes; Maintenance; Mediating; Membrane; Membrane Potentials; Mind; Mitochondria; Nature; Normal Cell; Outer Mitochondrial Membrane; Physiology; Play; Positioning Attribute; Production; Reactive Oxygen Species; Regulation; Resistance; Role; Seminal; Series; Staging; Stimulus; United States National Institutes of Health; cancer cell; experience; human disease; innovation; mitochondrial membrane; mutant; neutrophil; novel; prevent; progenitor; public health relevance; response

DESCRIPTION (provided by applicant): Anti-apoptotic BCL-2 family members regulate hematopoiesis and when dysregulated contribute to cancer, immunodeficiency, and autoimmunity. MCL-1 is absolutely required for cell survival at multiple stages of hematopoietic development. In contrast, genetic ablation of Bcl-2 or Bcl-X has revealed specific roles in promoting hematopoietic survival. Why MCL-1 plays such a critical role in maintaining survival and why the concomitant endogenous expression of other anti-apoptotic regulators cannot compensate for MCL-1 loss has remained unresolved. Therefore, the long term goal of my laboratory is to understand how MCL-1 functions and is regulated during hematopoietic development and survival. To understand the requirement for MCL-1 in development, we have recently identified that it localizes to both the outer mitochondrial membrane, where it MCL-1 binds and sequesters pro-apoptotic molecules, and to the mitochondrial inner membrane as an N- terminally truncated form. The contribution of both of these localizations to MCL-1's function is unclear. The objective of this proposal is to dissect the functional roles of the two mitochondrial forms of MCL-1 and to assess the individual roles of these localizations in promoting cellular survival. Our central hypothesis is that the outer membrane form of MCL-1 acts like "classical" BCL-2 family members to antagonize pro-apoptotics, while the inner membrane form of MCL-1 regulates cell survival by modulating mitochondrial function. The studies we propose will reveal a previously unrecognized role for MCL-1 and shed light onto a new mechanism by which an anti-apoptotic BCL-2 family member promotes mitochondrial function. Aim 1: Define the role(s) for the different mitochondrial forms of MCL-1 in regulating hematopoiesis. MCL-1 exhibits a profound requirement during many stages of hematopoiesis, but it is unclear why. Aim 2: Define the role(s) of inner mitochondrial MCL-1 in regulating apoptosis. Our preliminary studies indicate that only the outer mitochondrial form of MCL-1 is capable of binding and sequestering pro-apoptotic molecules. However, it is unclear whether the inner mitochondrial form of MCL-1 may alter response to death stimuli. Therefore, we will investigate how the different forms of MCL-1 contribute to its "classical" anti-apoptotic nature. Aim 3: Identify how MCL-1 regulates mitochondrial physiology. Our preliminary studies indicate that Mcl-1-deficiency results in abnormalities in mitochondrial physiology even when cells are not undergoing apoptosis. My laboratory has made many of the seminal findings defining the role of MCL-1 in promoting survival during hematopoiesis. Furthermore, we are uniquely positioned to successfully perform these studies as we have identified the novel localization, generated MCL-1 mutants that can dissect the different forms of MCL-1, and have extensive experience in MCL-1 biology. At the end of this study, we will have illuminated a previously unrecognized role for MCL-1 in promoting mitochondrial function. PUBLIC HEALTH RELEVANCE: Defects in the balance of cell survival and death can lead to a variety of human diseases including autoimmunity, immunodeficiency, and cancer. MCL-1 is a critical regulator of blood cell survival whose expression is tightly controlled in normal cells, but in cancerous cells such control is lost leading to inappropriate survival. This proposal is relevant to the goals of the National Institutes of Health because it investigates a novel role for MCL-1 in normal blood cells and will assess how MCL-1 can render cancer cells resistant to death.

描述(由申请人提供)：抗凋亡的bcl2家族成员调节造血，当失调时会导致癌症、免疫缺陷和自身免疫。MCL-1是细胞在多个造血发育阶段生存所必需的。相反，基因去除Bcl2或BclX在促进造血细胞存活方面显示了特定的作用。为什么MCL-1在维持生存中起着如此关键的作用，以及为什么伴随而来的其他抗凋亡调节因子的内源性表达不能弥补MCL-1的丢失，至今仍未解决。因此，我的实验室的长期目标是了解MCL-1在造血发育和生存过程中的功能和调节。为了了解MCL-1在发育过程中的需求，我们最近发现它既定位于线粒体外膜，在那里它结合和隔离促凋亡分子，又定位于线粒体内膜，以N端截断的形式存在。这两种定位对MCL-1‘S功能的贡献尚不清楚。这项建议的目的是剖析mcl1的两种线粒体形式的功能作用，并评估这些定位在促进细胞存活方面的单独作用。我们的中心假设是，MCL-1的外膜形式类似于经典的bcl-2家族成员，以对抗促凋亡分子，而内膜形式的MCL-1通过调节线粒体功能来调节细胞生存。我们提出的研究将揭示MCL-1以前未知的作用，并阐明抗凋亡的BCL-2家族成员促进线粒体功能的新机制。目的1：明确mcl1不同线粒体形态在造血调控中的作用(S)。MCL-1在造血的许多阶段都表现出深刻的需求，但原因尚不清楚。目的2：明确线粒体内MCL-1在细胞凋亡调控中的作用(S)。我们的初步研究表明，只有MCL-1的外部线粒体形式能够结合和隔离促凋亡分子。然而，目前尚不清楚MCL-1的内部线粒体形式是否会改变对死亡刺激的反应。因此，我们将研究不同形式的MCL-1如何对其经典的抗细胞凋亡特性做出贡献。目的3：研究MCL-1对线粒体生理的调节作用。我们的初步研究表明，Mcl-1缺乏会导致线粒体生理异常，即使细胞没有发生凋亡。我的实验室已经取得了许多开创性的发现，确定了MCL-1在促进造血过程中的存活方面的作用。此外，我们具有得天独厚的优势，可以成功地进行这些研究，因为我们已经确定了新的定位，产生了可以剖析不同形式的MCL-1的突变体，并且在MCL-1生物学方面拥有丰富的经验。在这项研究的最后，我们将阐明以前未被认识到的MCL-1在促进线粒体功能中的作用。 公共卫生相关性：细胞存活和死亡平衡的缺陷可能导致多种人类疾病，包括自身免疫、免疫缺陷和癌症。MCL-1是血细胞存活的关键调节因子，其表达在正常细胞中受到严格控制，但在癌细胞中失去这种控制，导致不适当的生存。这项建议与美国国立卫生研究院的目标相关，因为它调查了MCL-1在正常血细胞中的一个新角色，并将评估MCL-1如何使癌细胞抵抗死亡。